Departamento de Biología Celular, Laboratorio de Neurobiología y células madres Neuro-CellTT, Centro de Microscopía Avanzada CMA BIOBIO, Facultad de Ciencias Biológicas, Universidad de Concepción, Concepción, Chile.
J Cell Physiol. 2019 Nov;234(11):19331-19338. doi: 10.1002/jcp.28637. Epub 2019 Apr 8.
For a long time, the effect of vitamin C on cancer cells has been a controversial concept. From Linus Pauling's studies in 1976, it was proposed that ascorbic acid (AA) could selectively kill tumor cells. However, further research suggested that vitamin C has no effect on tumor survival. In the last decade, new and emerging functions for vitamin C have been discovered using the reduced form, AA, and the oxidized form, dehydroascorbic acid (DHA), independently. In this review, we summarized the latest findings related to the effects of DHA on the survival and metabolism of tumor cells. At the same time, we put special emphasis on the bystander effect and the recycling capacity of vitamin C in various cellular models, and how these concepts can affect the experimentation with vitamin C and its therapeutic application in the treatment against cancer.
长期以来,维生素 C 对癌细胞的影响一直是一个有争议的概念。从莱纳斯·鲍林(Linus Pauling)在 1976 年的研究开始,就有人提出抗坏血酸(AA)可以选择性地杀死肿瘤细胞。然而,进一步的研究表明,维生素 C 对肿瘤的存活没有影响。在过去的十年中,使用还原形式 AA 和氧化形式脱氢抗坏血酸(DHA),分别发现了维生素 C 的新的和新兴的功能。在这篇综述中,我们总结了与 DHA 对肿瘤细胞存活和代谢影响相关的最新发现。同时,我们特别强调了旁观者效应和维生素 C 在各种细胞模型中的再循环能力,以及这些概念如何影响维生素 C 的实验及其在癌症治疗中的治疗应用。